Comment
doi: 10.1007/s10549-017-4109-8.
Epub 2017 Jan 16.
Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?
Affiliations
- PMID: 28091861
- DOI: 10.1007/s10549-017-4109-8
Item in Clipboard
Comment
Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?
Breast Cancer Res Treat.
2017 Apr.
No abstract available
Comment in
-
Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?".Breast Cancer Res Treat. 2017 Apr;162(2):397-398. doi: 10.1007/s10549-017-4114-y. Breast Cancer Res Treat. 2017. PMID: 28110478 No abstract available.
Comment on
-
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.Breast Cancer Res Treat. 2017 Feb;161(3):549-556. doi: 10.1007/s10549-016-4080-9. Epub 2016 Dec 20. Breast Cancer Res Treat. 2017. PMID: 28000014
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
